Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice

Hypertension. 2014 Feb;63(2):265-72. doi: 10.1161/HYPERTENSIONAHA.113.02289. Epub 2013 Nov 4.

Abstract

Apolipoprotein E-deficient (apoE(-/-)) mice fed on Western diet are characterized by increased vascular resistance and atherosclerosis. Previously, we have shown that chronic angiotensin (Ang)-(1-7) treatment ameliorates endothelial dysfunction in apoE(-/-) mice. However, the mechanism of Ang-(1-7) on vasoconstrictor response to Ang II is unknown. To examine Ang-(1-7) function, we used apoE(-/-) and wild-type mice fed on Western diet that were treated via osmotic minipumps either with Ang-(1-7) (82 μg/kg per hour) or saline for 6 weeks. We show that Ang II-induced renal pressor response was significantly increased in apoE(-/-) compared with wild-type mice. This apoE(-/-)-specific response is attributed to reactive oxygen species-mediated p38 mitogen-activated protein kinase activation and subsequent phosphorylation of myosin light chain (MLC(20)), causing renal vasoconstriction. Here, we provide evidence that chronic Ang-(1-7) treatment attenuated the renal pressor response to Ang II in apoE(-/-) mice to wild-type levels. Ang-(1-7) treatment significantly decreased renal inducible nicotinamide adenine dinucleotide phosphate subunit p47phox levels and, thus, reactive oxygen species production that in turn causes decreased p38 mitogen-activated protein kinase activity. The latter has been confirmed by administration of a specific p38 mitogen-activated protein kinase inhibitor SB203580 (5 μmol/L), causing a reduced renal pressor response to Ang II in apoE(-/-) but not in apoE(-/-) mice treated with Ang-(1-7). Moreover, Ang-(1-7) treatment had no effect in Mas(-/-)/apoE(-/-) double-knockout mice confirming the specificity of Ang-(1-7) action through the Mas-receptor. In summary, Ang-(1-7) modulates vascular function via Mas-receptor activation that attenuates pressor response to Ang II in apoE(-/-) mice by reducing reactive oxygen species-mediated p38 mitogen-activated protein kinase activity.

Keywords: angiotensin-(1–7); apolipoprotein E; p38 mitogen-activated protein kinase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin I / metabolism
  • Angiotensin I / pharmacology*
  • Angiotensin II / metabolism
  • Animals
  • Apolipoproteins E / genetics
  • Atherosclerosis / genetics
  • Atherosclerosis / metabolism
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Disease Models, Animal
  • Female
  • Hypertension, Renal / drug therapy*
  • Hypertension, Renal / genetics
  • Hypertension, Renal / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Naphthalenes / pharmacology*
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Peptide Fragments / metabolism
  • Peptide Fragments / pharmacology*
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / genetics
  • Pyrazoles / pharmacology*
  • Receptors, G-Protein-Coupled / genetics
  • Renal Circulation / drug effects*
  • Renal Circulation / physiology
  • Vascular Resistance / drug effects*
  • Vascular Resistance / physiology
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Apolipoproteins E
  • Naphthalenes
  • Peptide Fragments
  • Protein Kinase Inhibitors
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Pyrazoles
  • Receptors, G-Protein-Coupled
  • Angiotensin II
  • Angiotensin I
  • p38 Mitogen-Activated Protein Kinases
  • doramapimod
  • angiotensin I (1-7)